OSIRIS THERAPEUTICS, INC. 4
4 · OSIRIS THERAPEUTICS, INC. · Filed Nov 20, 2015
Insider Transaction Report
Form 4
Debrabandere Lode
Vice President
Transactions
- Exercise/Conversion
Common Stock
2015-11-20$6.84/sh+37,500$256,500→ 37,500 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2015-11-20$6.84/sh−37,500$256,500→ 410,000 totalExercise: $6.84From: 2007-07-31Exp: 2016-07-31→ Common Stock (37,500 underlying)